Synthesis and calcium channel modulating effects of modified Hantzsch nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(pyridinyl or 2-trifluoromethylphenyl)-5-pyridinecarboxylates

Drug Development Research

Volumn 51, Issue 4, 2000, Pages 225-232

  Miri, Ramin ^a   McEwen, Carol Anne ^a   Knaus, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

1,4 dihydropyridines; Calcium channels; Inotropic effects; Nitrooxyalkyl; Smooth muscle relaxation

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; DIHYDROPYRIDINE DERIVATIVE; NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; GUINEA PIG; IC 50; ILEUM; INOTROPISM; NONHUMAN; REACTION ANALYSIS; SMOOTH MUSCLE; STRUCTURE ACTIVITY RELATION;

EID: 0034465082     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.3     Document Type: Article

References (17)

1. 2+ release channel from oxidation induced activation. J Biol Chem 272:25462-25467.
2. Butler AR, Williams DHL. 1993. The physiological role of nitric oxide. Chem Soc Rev 22:233-241; and references therein.
3. Christiaans JAM, Timmerman H. 1996. Cardiovascular hybrid drugs: combination of more than one pharmacological property in one single molecule. Eur J Pharm Sci 4:1-22.
4. Conti CR. 1987. Use of nitrates in unstable angina pectoris. Am J Cardiol 60:31H-34H.
5. Dagnino L, Li-Kwong-Ken MC, Wolowyk MW, Wynn II, Triggle CR, Knaus EE. 1987. Synthesis and calcium channel antagonist activity of dialkyl 4-(dihydropyridinyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates. J Med Chem 30:640-646.
6. Dhein S, Zhao Y, Simsek S, Salameh A, Klaus W. 1995. Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds. J Cardiovasc Pharmacol 26:784-791.
7. Furchgott RE Zawadzki JV. 1980. The obligatorry role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376.
8. Gasco A, Fruttero R, Sorba G. 1996. NO-donors: an emerging class of compounds in medicinal chemistry- Il Farmaco 51:617-635.
9. Gunnar RM, Fisch C. 1990. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). Circulation 82:664-707.
10. Holzmann S. 1983. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75). J Cardiovasc Pharmacol 5:364-370.
11. Hurd CD, Nilson ME. 1955. Aliphatic nitroketones. J Org Chem 20:927-936.
12. Iqbal N, Knaus EE. 1996. Synthesis and smooth muscle calcium channel antagonist effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrooxy or nitrophenyl moiety in the 3-alkyl ester substituent. Arch Pharm-Pharm Med Chem 329:23-26.
13. Kerwin JF, Lancaster JR, Feldman PL. 1995. Nitric oxide: a new paradigm for second messengers. J Med Chem 38:4343-4362.
14. Liu JJ, Johnston CI, Buxton BE 1994. Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery. J Pharmacol Exp Ther 268:434-440.
15. Luscher TF, Yang Z. 1993. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle. Drugs 46 (Suppl. 2):121-132.
16. McGregor M. 1983. Pathogenesis of angina pectoris and role of nitrates in relief of myocardial ischemia. Am J Med 74:21-27.
17. Ogawa T, Nakazato A, Tsuchida K, Hatayama K. 1993. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position. Chem Pharm Bull 41:108-116.